Genomic

Dataset Information

0

Transcriptome Sequencing of Pediatric Neuroblastoma


ABSTRACT:

Neuroblastoma is the most common extra-cranial solid tumor in children. It represents 8% to 10% of all childhood cancers. Stage 4 Neuroblastoma is characterized by its clinical heterogeneous outcome. The special category, stage 4S tumors (2-5% of all NB) are chemo-sensitive, and the patients show spontaneous regression. On the other hand, MYCN amplification (25-30% of all NB) is associated with poor outcome of neuroblastoma, thus we further categorize stage 4 neuroblastoma into MYCN non-amplified and MYCN amplified group. Here we use transcriptome sequencing to characterize the transcriptome in 29 stage 4 Neuroblastoma samples.

PROVIDER: phs000868 | dbGaP |

SECONDARY ACCESSION(S): PRJNA275174PRJNA275173

REPOSITORIES: dbGaP

Dataset's files

Source:
Action DRS
GapExchange_phs000868.v1.p1.xml Xml
dbGaPEx2.1.5.xsd Other
Study_Report.phs000868.PediatricNeuroblastoma.v1.p1.MULTI.pdf Pdf
manifest_phs000868.PediatricNeuroblastoma.v1.p1.c1.GRU.pdf Pdf
datadict_v2.xsl Other
Items per page:
1 - 5 of 15

Similar Datasets

2011-09-29 | E-GEOD-25624 | biostudies-arrayexpress
2020-05-22 | ST001405 | MetabolomicsWorkbench
2011-09-30 | GSE25624 | GEO
2024-08-29 | PXD054441 | Pride
2020-07-15 | GSE74198 | GEO
2023-05-10 | PXD039332 | Pride
2021-10-13 | GSE156092 | GEO
| 2156647 | ecrin-mdr-crc
2010-12-31 | GSE22182 | GEO
2021-11-11 | PXD026876 | Pride